| http://dbpedia.org/ontology/abstract
|
HU-210 — синтетический каннабиноид класса дибензопиранов.
, HU-210 (Hebrew University 210) – organiczn … HU-210 (Hebrew University 210) – organiczny związek chemiczny z grupy syntetycznych kannabinoidów. Po raz pierwszy otrzymany na Hebrew University przez Raphaela Mechoulama w 1988 roku. Jest substancją psychoaktywną, 100 do 800 razy bardziej aktywną od THC, a efekty jego działania utrzymują się znacznie dłużej. HU-210 stymuluje neurogenezę w rejonie hipokampu, jest to działanie odwrotne do alkoholu, heroiny, nikotyny i kokainy. Jest rozpuszczalny w wodzie.ny i kokainy. Jest rozpuszczalny w wodzie.
, HU-210 ist ein synthetisches Cannabinoid. … HU-210 ist ein synthetisches Cannabinoid. Das Kürzel HU steht für Hebrew University, wo die Verbindung von der Arbeitsgruppe von Raphael Mechoulam synthetisiert wurde. HU-210 ist 100 bis 800 mal wirksamer als das natürliche Tetrahydrocannabinol aus der Hanfpflanze und besitzt eine längere Wirkungsdauer. HU-210 ist das (–)-1,1-Dimethylheptyl-Analogon des 11-Hydroxy-Δ8-tetrahydrocannabinol und wird auch 1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol genannt.yl-11-hydroxytetrahydrocannabinol genannt.
, HU-210 is a synthetic cannabinoid that was … HU-210 is a synthetic cannabinoid that was first synthesized in 1988 from by a group led by Raphael Mechoulam at the Hebrew University. HU-210 is 100 to 800 times more potent than natural THC from cannabis and has an extended duration of action. HU-210 has a binding affinity of 0.061nM at CB1 and 0.52nM at CB2 in cloned human cannabinoid receptors. Compared to Delta-9-THC of 40.7nM at CB1. HU-210 is the (–)-1,1-dimethylheptyl analog of 11-hydroxy- Δ8- tetrahydrocannabinol; in some references it is called 1,1-dimethylheptyl- 11-hydroxytetrahydrocannabinol. The abbreviation "HU" stands for Hebrew University.viation "HU" stands for Hebrew University.
, L'HU-210 è un cannabinoide sintetico messo … L'HU-210 è un cannabinoide sintetico messo a punto nel 1988 dal gruppo del prof. Raphael Mechoulam della Università Ebraica di Gerusalemme. Un recente lavoro pubblicato sul (vedi bibliografia), mostra che l'HU-210 stimola la neurogenesi delle cellule nervose dell'ippocampo, esercitando un effetto ansiolitico e antidepressivo.o un effetto ansiolitico e antidepressivo.
|
| http://dbpedia.org/ontology/casNumber
|
112830-95-2
|
| http://dbpedia.org/ontology/chEMBL
|
307696
|
| http://dbpedia.org/ontology/fdaUniiCode
|
191042422P
|
| http://dbpedia.org/ontology/pubchem
|
9821569
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/HU-210_structure.svg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.samhsa.gov/data/sites/default/files/SR-1378/SR-1378.pdf +
|
| http://dbpedia.org/ontology/wikiPageID
|
1461877
|
| http://dbpedia.org/ontology/wikiPageLength
|
21122
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1101763782
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Myrtenol +
, http://dbpedia.org/resource/HU-331 +
, http://dbpedia.org/resource/Mescaline +
, http://dbpedia.org/resource/Controlled_substance +
, http://dbpedia.org/resource/Cannabinoid_receptor +
, http://dbpedia.org/resource/Florida +
, http://dbpedia.org/resource/Cannabinoid_receptor_type_2 +
, http://dbpedia.org/resource/Category:HU_cannabinoids +
, http://dbpedia.org/resource/Cannabinoid_receptor_type_1 +
, http://dbpedia.org/resource/Synthetic_cannabinoid +
, http://dbpedia.org/resource/Neural +
, http://dbpedia.org/resource/Stramonium +
, http://dbpedia.org/resource/HU-211 +
, http://dbpedia.org/resource/List_of_Schedule_I_drugs_%28US%29 +
, http://dbpedia.org/resource/Structural_analog +
, http://dbpedia.org/resource/WIN_55%2C212-2 +
, http://dbpedia.org/resource/JWH-018 +
, http://dbpedia.org/resource/Cannabinoid +
, http://dbpedia.org/resource/Hebrew_University +
, http://dbpedia.org/resource/HU-320 +
, http://dbpedia.org/resource/HU-345 +
, http://dbpedia.org/resource/Convention_on_Psychotropic_Substances +
, http://dbpedia.org/resource/%281R%2C5S%29-myrtenol +
, http://dbpedia.org/resource/United_Nations +
, http://dbpedia.org/resource/1%2C1-Dimethylheptylresorcinol +
, http://dbpedia.org/resource/File:HU-210_synthesis.svg +
, http://dbpedia.org/resource/Psilocybin +
, http://dbpedia.org/resource/Chemical_synthesis +
, http://dbpedia.org/resource/Antidepressant +
, http://dbpedia.org/resource/G_proteins +
, http://dbpedia.org/resource/Isomers +
, http://dbpedia.org/resource/Hallucinogen +
, http://dbpedia.org/resource/11-Hydroxy-Delta-8-THC +
, http://dbpedia.org/resource/Antianxiety +
, http://dbpedia.org/resource/Enantiomer +
, http://dbpedia.org/resource/Cellular_differentiation +
, http://dbpedia.org/resource/Controlled_Substances_Act +
, http://dbpedia.org/resource/Category:Phenols +
, http://dbpedia.org/resource/CP_47%2C497 +
, http://dbpedia.org/resource/Federal_government_of_the_United_States +
, http://dbpedia.org/resource/Amyloid_beta +
, http://dbpedia.org/resource/Neural_stem_cell +
, http://dbpedia.org/resource/Category:Primary_alcohols +
, http://dbpedia.org/resource/Raphael_Mechoulam +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Tetrahydrocannabinol +
, http://dbpedia.org/resource/NMDA_antagonist +
, http://dbpedia.org/resource/Cell_proliferation +
, http://dbpedia.org/resource/Drug_Enforcement_Administration +
, http://dbpedia.org/resource/HU-336 +
, http://dbpedia.org/resource/Cannabis_sativa +
, http://dbpedia.org/resource/HU-308 +
, http://dbpedia.org/resource/Neuroprotective +
, http://dbpedia.org/resource/Hippocampal +
, http://dbpedia.org/resource/HU-239 +
, http://dbpedia.org/resource/Alzheimer%27s_disease +
, http://dbpedia.org/resource/Cannabis_%28drug%29 +
, http://dbpedia.org/resource/Microglia +
, http://dbpedia.org/resource/Lysergic_acid_diethylamide +
, http://dbpedia.org/resource/Drug_possession +
, http://dbpedia.org/resource/Peyote +
, http://dbpedia.org/resource/THC +
, http://dbpedia.org/resource/Dexanabinol +
, http://dbpedia.org/resource/MAPK/ERK_pathway +
, http://dbpedia.org/resource/Progenitor_cell +
, http://dbpedia.org/resource/JWH-133 +
, http://dbpedia.org/resource/Federal_Analogue_Act +
, http://dbpedia.org/resource/Single_Convention_on_Narcotic_Drugs +
, http://dbpedia.org/resource/Analgesic +
, http://dbpedia.org/resource/Category:Benzochromenes +
, http://dbpedia.org/resource/Alabama +
, http://dbpedia.org/resource/HU-243 +
|
| http://dbpedia.org/property/c
|
25
|
| http://dbpedia.org/property/casNumber
|
112830
|
| http://dbpedia.org/property/chembl
|
307696
|
| http://dbpedia.org/property/chemspiderid
|
7997318
|
| http://dbpedia.org/property/h
|
38
|
| http://dbpedia.org/property/image
|
Hu210_bns.png
|
| http://dbpedia.org/property/iupacName
|
-9
|
| http://dbpedia.org/property/iupharLigand
|
731
|
| http://dbpedia.org/property/legalCa
|
Schedule II
|
| http://dbpedia.org/property/legalUk
|
Class B
|
| http://dbpedia.org/property/legalUs
|
unScheduled
|
| http://dbpedia.org/property/o
|
3
|
| http://dbpedia.org/property/pubchem
|
9821569
|
| http://dbpedia.org/property/smiles
|
CCCCCCCC1=CC2=CCO
|
| http://dbpedia.org/property/stdinchi
|
1
|
| http://dbpedia.org/property/stdinchikey
|
SSQJFGMEZBFMNV-WOJBJXKFSA-N
|
| http://dbpedia.org/property/synonyms
|
11
|
| http://dbpedia.org/property/unii
|
1.91042422E8
|
| http://dbpedia.org/property/verifiedfields
|
changed
|
| http://dbpedia.org/property/verifiedrevid
|
400102655
|
| http://dbpedia.org/property/watchedfields
|
changed
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Cannabinoids +
, http://dbpedia.org/resource/Template:Quote +
, http://dbpedia.org/resource/Template:Cannabinoidergics +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Stdinchicite +
, http://dbpedia.org/resource/Template:Colend +
, http://dbpedia.org/resource/Template:Cascite +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Chemspidercite +
, http://dbpedia.org/resource/Template:Refend +
, http://dbpedia.org/resource/Template:Refbegin +
, http://dbpedia.org/resource/Template:Cite_journal +
, http://dbpedia.org/resource/Template:Cquote +
, http://dbpedia.org/resource/Template:Ebicite +
, http://dbpedia.org/resource/Template:Hallucinogens +
, http://dbpedia.org/resource/Template:Colbegin +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Drugbankcite +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Primary_alcohols +
, http://dbpedia.org/resource/Category:HU_cannabinoids +
, http://dbpedia.org/resource/Category:Designer_drugs +
, http://dbpedia.org/resource/Category:Benzochromenes +
, http://dbpedia.org/resource/Category:Phenols +
|
| http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Cannabinoid +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/HU-210?oldid=1101763782&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/HU-210_structure.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/HU-210_synthesis.svg +
, http://commons.wikimedia.org/wiki/Special:FilePath/Hu210_bns.png +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/HU-210 +
|
| owl:sameAs |
https://global.dbpedia.org/id/3okvW +
, http://sh.dbpedia.org/resource/HU-210 +
, http://dbpedia.org/resource/HU-210 +
, http://rdf.freebase.com/ns/m.053fbs +
, http://www.wikidata.org/entity/Q411905 +
, http://yago-knowledge.org/resource/HU-210 +
, http://sr.dbpedia.org/resource/HU-210 +
, http://pl.dbpedia.org/resource/HU-210 +
, http://azb.dbpedia.org/resource/%D8%A7%DA%86_%DB%8C%D9%88_-210 +
, http://hr.dbpedia.org/resource/HU-210 +
, http://ru.dbpedia.org/resource/HU-210 +
, http://de.dbpedia.org/resource/HU-210 +
, http://it.dbpedia.org/resource/HU-210 +
|
| rdf:type |
http://dbpedia.org/class/yago/CausalAgent100007347 +
, http://dbpedia.org/class/yago/Part113809207 +
, http://dbpedia.org/class/yago/Liquid114940386 +
, http://dbpedia.org/class/yago/Beverage107881800 +
, http://dbpedia.org/class/yago/Food100021265 +
, http://dbpedia.org/class/yago/Abbreviation107091587 +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/Drug103247620 +
, http://dbpedia.org/class/yago/Agent114778436 +
, http://dbpedia.org/class/yago/DrugOfAbuse103248958 +
, http://dbpedia.org/class/yago/LanguageUnit106284225 +
, http://dbpedia.org/class/yago/WikicatAlcohols +
, http://dbpedia.org/class/yago/WikicatPhenols +
, http://dbpedia.org/class/yago/Phenol114989545 +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Form106290637 +
, http://dbpedia.org/class/yago/HeterocyclicCompound115025397 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/WikicatOxygenHeterocycles +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://dbpedia.org/class/yago/WikicatAbbreviations +
, http://dbpedia.org/class/yago/Word106286395 +
, http://dbpedia.org/class/yago/Fluid114939900 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Alcohol107884567 +
, http://dbpedia.org/class/yago/Substance100020090 +
, http://www.wikidata.org/entity/Q8386 +
, http://umbel.org/umbel/rc/DrugProduct +
|
| rdfs:comment |
HU-210 is a synthetic cannabinoid that was … HU-210 is a synthetic cannabinoid that was first synthesized in 1988 from by a group led by Raphael Mechoulam at the Hebrew University. HU-210 is 100 to 800 times more potent than natural THC from cannabis and has an extended duration of action. HU-210 has a binding affinity of 0.061nM at CB1 and 0.52nM at CB2 in cloned human cannabinoid receptors. Compared to Delta-9-THC of 40.7nM at CB1. HU-210 is the (–)-1,1-dimethylheptyl analog of 11-hydroxy- Δ8- tetrahydrocannabinol; in some references it is called 1,1-dimethylheptyl- 11-hydroxytetrahydrocannabinol. The abbreviation "HU" stands for Hebrew University.viation "HU" stands for Hebrew University.
, HU-210 ist ein synthetisches Cannabinoid. … HU-210 ist ein synthetisches Cannabinoid. Das Kürzel HU steht für Hebrew University, wo die Verbindung von der Arbeitsgruppe von Raphael Mechoulam synthetisiert wurde. HU-210 ist 100 bis 800 mal wirksamer als das natürliche Tetrahydrocannabinol aus der Hanfpflanze und besitzt eine längere Wirkungsdauer. HU-210 ist das (–)-1,1-Dimethylheptyl-Analogon des 11-Hydroxy-Δ8-tetrahydrocannabinol und wird auch 1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol genannt.yl-11-hydroxytetrahydrocannabinol genannt.
, HU-210 — синтетический каннабиноид класса дибензопиранов.
, HU-210 (Hebrew University 210) – organiczn … HU-210 (Hebrew University 210) – organiczny związek chemiczny z grupy syntetycznych kannabinoidów. Po raz pierwszy otrzymany na Hebrew University przez Raphaela Mechoulama w 1988 roku. Jest substancją psychoaktywną, 100 do 800 razy bardziej aktywną od THC, a efekty jego działania utrzymują się znacznie dłużej. HU-210 stymuluje neurogenezę w rejonie hipokampu, jest to działanie odwrotne do alkoholu, heroiny, nikotyny i kokainy. Jest rozpuszczalny w wodzie.ny i kokainy. Jest rozpuszczalny w wodzie.
, L'HU-210 è un cannabinoide sintetico messo … L'HU-210 è un cannabinoide sintetico messo a punto nel 1988 dal gruppo del prof. Raphael Mechoulam della Università Ebraica di Gerusalemme. Un recente lavoro pubblicato sul (vedi bibliografia), mostra che l'HU-210 stimola la neurogenesi delle cellule nervose dell'ippocampo, esercitando un effetto ansiolitico e antidepressivo.o un effetto ansiolitico e antidepressivo.
|
| rdfs:label |
HU-210
|
